CN110940807A - Method for researching expression of bombyx mori gene for inhibiting BmNPV DNA replication related gene - Google Patents
Method for researching expression of bombyx mori gene for inhibiting BmNPV DNA replication related gene Download PDFInfo
- Publication number
- CN110940807A CN110940807A CN201911086586.7A CN201911086586A CN110940807A CN 110940807 A CN110940807 A CN 110940807A CN 201911086586 A CN201911086586 A CN 201911086586A CN 110940807 A CN110940807 A CN 110940807A
- Authority
- CN
- China
- Prior art keywords
- recombinant
- bmlispase
- dbp
- gene
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000255789 Bombyx mori Species 0.000 title claims abstract description 114
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 96
- 230000014509 gene expression Effects 0.000 title claims abstract description 55
- 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 45
- 230000004543 DNA replication Effects 0.000 title claims abstract description 19
- 230000002401 inhibitory effect Effects 0.000 title abstract description 12
- 241000700605 Viruses Species 0.000 claims abstract description 57
- 239000013612 plasmid Substances 0.000 claims abstract description 32
- 230000027455 binding Effects 0.000 claims abstract description 24
- 230000000694 effects Effects 0.000 claims abstract description 22
- 238000011160 research Methods 0.000 claims abstract description 20
- 230000029812 viral genome replication Effects 0.000 claims abstract description 13
- 238000010367 cloning Methods 0.000 claims abstract description 10
- 230000008859 change Effects 0.000 claims abstract description 8
- 241000588724 Escherichia coli Species 0.000 claims abstract description 4
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 4
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 4
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 4
- 208000015181 infectious disease Diseases 0.000 claims description 18
- 238000010276 construction Methods 0.000 claims description 13
- 238000001262 western blot Methods 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 10
- 239000002299 complementary DNA Substances 0.000 claims description 9
- 239000013598 vector Substances 0.000 claims description 9
- 108060004795 Methyltransferase Proteins 0.000 claims description 6
- 101710182846 Polyhedrin Proteins 0.000 claims description 5
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 5
- 238000012795 verification Methods 0.000 claims description 5
- 238000013461 design Methods 0.000 claims description 4
- 238000010839 reverse transcription Methods 0.000 claims description 3
- 108700008625 Reporter Genes Proteins 0.000 claims 1
- 230000006916 protein interaction Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 28
- 230000010076 replication Effects 0.000 abstract description 13
- 230000007246 mechanism Effects 0.000 abstract description 11
- 230000005764 inhibitory process Effects 0.000 abstract description 9
- 230000035755 proliferation Effects 0.000 abstract description 9
- 230000009471 action Effects 0.000 abstract description 5
- 230000003993 interaction Effects 0.000 abstract description 5
- 230000002194 synthesizing effect Effects 0.000 abstract description 4
- 230000001131 transforming effect Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 61
- 108020004414 DNA Proteins 0.000 description 41
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 22
- 101710096438 DNA-binding protein Proteins 0.000 description 19
- 239000000523 sample Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 15
- 239000013615 primer Substances 0.000 description 11
- 239000012528 membrane Substances 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 108020001507 fusion proteins Proteins 0.000 description 9
- 102000037865 fusion proteins Human genes 0.000 description 9
- 230000003612 virological effect Effects 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 241000238631 Hexapoda Species 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 7
- 238000001976 enzyme digestion Methods 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 102000009096 Proto-Oncogene Proteins c-myb Human genes 0.000 description 6
- 108010087776 Proto-Oncogene Proteins c-myb Proteins 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 241000701447 unidentified baculovirus Species 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 101000972316 Autographa californica nuclear polyhedrosis virus Late expression factor 3 Proteins 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 238000000636 Northern blotting Methods 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000006180 TBST buffer Substances 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 101150026402 DBP gene Proteins 0.000 description 3
- 230000006820 DNA synthesis Effects 0.000 description 3
- 101710116602 DNA-Binding protein G5P Proteins 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 101710162453 Replication factor A Proteins 0.000 description 3
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 description 3
- 101710176276 SSB protein Proteins 0.000 description 3
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000012148 binding buffer Substances 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000009465 prokaryotic expression Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 230000005727 virus proliferation Effects 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 101710202747 Alkaline nuclease Proteins 0.000 description 2
- 238000011537 Coomassie blue staining Methods 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 241000255777 Lepidoptera Species 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000010414 supernatant solution Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 2
- 230000007442 viral DNA synthesis Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 210000002845 virion Anatomy 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 101710197637 Actin-3 Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 101000662893 Arabidopsis thaliana Telomere repeat-binding factor 1 Proteins 0.000 description 1
- 101000662890 Arabidopsis thaliana Telomere repeat-binding factor 2 Proteins 0.000 description 1
- 101000662891 Arabidopsis thaliana Telomere repeat-binding factor 3 Proteins 0.000 description 1
- 101000662896 Arabidopsis thaliana Telomere repeat-binding factor 4 Proteins 0.000 description 1
- 101000662897 Arabidopsis thaliana Telomere repeat-binding factor 5 Proteins 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 101150045511 LEF-11 gene Proteins 0.000 description 1
- 101150117484 LEF-2 gene Proteins 0.000 description 1
- 101710084373 Lipase 1 Proteins 0.000 description 1
- 102100022699 Lymphoid enhancer-binding factor 1 Human genes 0.000 description 1
- 108090001093 Lymphoid enhancer-binding factor 1 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101000981790 Oryza sativa subsp. japonica Transcription factor MYB2 Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000013616 RNA primer Substances 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 241000156523 Symphitoneuria exigua Species 0.000 description 1
- -1 TRIzol Substances 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008011 embryonic death Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 108010073221 viral alkaline nuclease Proteins 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
- G01N2333/92—Triglyceride splitting, e.g. by means of lipase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a method for researching the expression of bombyx mori genes for inhibiting BmNPV DNA replication related genes, which comprises the following steps: (1) designing a primer for synthesizing cloning according to steps required by plasmid cloning; (2) constructing a recombinant plasmid pFastBacDual-polyhedrin-A3-Bmlispase-1 by the recombinant plasmid; (3) constructing recombinant viruses, namely transforming E.coli DH10Bac delta EGT cells by using the recombinant plasmids prepared in the step (2) to construct recombinant Bacmid; (4) verifying and verifying the influence of the recombinant Bacmid prepared in the step (3) on the BmNPV DNA replication related gene; verifying the expression quantity change of DBP; the EMSA method verifies the interaction between the protein and the nucleic acid; analyzing the dbp promoter activity of the deleted Bmlispase-1 binding site. Compared with the prior art, the invention has the following advantages: the invention analyzes the influence of Bmlispase-1 on virus replication related genes in cells on the basis of constructing recombinant viruses capable of expressing the Bmlispase-1, and researches the action site of the Bmlispase-1 by using EMSA, thereby clarifying the mechanism of the BmlnpV replication and proliferation inhibition of the Bmlispase-1.
Description
Technical Field
The invention belongs to the technical field of molecular biology, and relates to a method for researching a mechanism for inhibiting BmNPV amplification by silkworm virus-resistant related genes, in particular to a method for researching the expression of BmNPV DNA replication-related genes inhibited by silkworm genes.
Background
The economic loss of silkworm nuclear polyhedrosis virus (BmNPV) caused by silkworm nuclear polyhedrosis virus infection to Chinese silkworm breeding accounts for about 70-80% of the total loss of silkworm diseases. The identification of resistance mechanism and resistance gene of bombyx mori against BmNPV has been an important research topic in the silkworm industry, and many advances have been made so far. After BmNPV enters the digestive tract of silkworms through the infection route under food, the resistance of silkworms to viruses is divided into 2 aspects: certain proteins such as alkaline protease which are present in the midgut cells and block virus infection activate the blocking mechanism of the midgut cells on virus replication and proliferation; when the virus is replicated and proliferated in midgut cells, so that the midgut cells are destroyed and spread to a body cavity, the silkworm cells start an apoptosis program, wherein some important proteins related to apoptosis in digestive fluid, such as serine protease and the like, play roles in inhibiting the replication and the spread of the virus.
The gene I of the lipase belongs to α/β hydrolase family, the gene I of the silkworm lipase (Bombyx mori lipase-1, Bmlispase-1) plays a dual role in the digestive tract of the silkworm, plays an important role in regulating physiological functions in the feeding stage, improves the resistance of the BmNPV of the silkworm body during a large amount of feeding, belongs to an important component part which is indispensable in an immunity mechanism, the Bmlispase-1 is obtained by first separation and purification in 2003, the gene is specifically expressed in the midgut tissue of the silkworm and has strong BmNPV resistance activity, the Bmlispase-1 in the midgut tissue of a susceptible strain 306 infected with the BmNPV has weak up-regulation (12h), the expression amount of Bmlispase-1 mRNA in the midgut of different strains is positively correlated with the resistance of the silkworm body to the BmNPV, and the Bmlispase-1 can be induced to be regulated within a certain time period after the BmNPV is infected with the silkworm body, and the Bmlnpv resistance of the Bmlispase-1 of the silkworm is obviously increased by about 30 percent.
Currently, some studies have been made on the resistance of insects to baculovirus. The research of silkworm inhibition of BmNPV infection is a hot spot in the silkworm industry. The protein in the midgut and blood of the silkworm can inhibit the infection of BmNPV through immune activation and apoptosis. The silkworm proteins with the activity of resisting BmNPV comprise Bmlispase-1, BmPP2A, BmEPCK-2 and BmATLAStin-n; BmPGRP2-2 can stimulate the replication of virus in cells; the lipase gene of silkworm intestinal bacteria Bacillus pumilus SW41 also has BmNPV resistance activity. However, the mechanism of resistance of these proteins to BmNPV has not been fully elucidated. However, the establishment of the transgenic cell line requires a long time, and the insect cell culture has the characteristics of easy pollution, long culture time and easy degeneration, so the establishment of the transgenic cell line is difficult.
Disclosure of Invention
The technical problem to be solved is as follows: in order to overcome the defects of the prior art, the invention analyzes the influence of Bmlispase-1 on virus replication related genes in cells on the basis of constructing recombinant viruses capable of expressing the Bmlispase-1, and researches the action site of the Bmlispase-1 by using EMSA, thereby clarifying the mechanism of inhibiting the replication and proliferation of BmNPV by the Bmlispase-1. The research provides a new theoretical basis for preventing and treating lepidoptera insect viruses and provides a new idea for further discussing the inhibition mechanism of silkworm genes on the viruses.
The technical scheme is as follows: a method of studying the expression of bombyx mori genes to inhibit BmNPV DNA replication associated genes, the method comprising the steps of:
(1) primer design
Designing primers for synthesizing and cloning according to steps required by plasmid cloning;
(2) construction of recombinant plasmids
Constructing a recombinant plasmid pFastBacDual-polyhedrin-A3-Bmlispase-1;
(3) recombinant virus construction
Transforming the recombinant plasmid prepared in the step (2) into E.coli DH10Bac delta EGT cells to construct recombinant Bacmid;
(4) result verification
Verifying the influence of the recombinant Bacmid prepared in the step (3) on the BmNPV DNA replication related gene; verifying the expression quantity change of DBP; the EMSA method verifies the interaction between the protein and the nucleic acid; analyzing the dbp promoter activity of the deleted Bmlispase-1 binding site.
Preferably, the specific construction method of the recombinant plasmid pFastBacDual-polyhedrin-A3-Bmlispase-1 in the step (2) is as follows: taking BmNPV genome as a template, cloning polyhedrin by PCR with a primer Polyhe-F/R (the primer sequence is shown in Table 1), carrying out double enzyme digestion by BamHI/hindIII, and connecting the cloned polyhedrin to pFastBacDual to obtain a recombinant vector pFastBacDual-polyhedrin; taking pPIGA3GFP plasmid as a template, carrying out PCR amplification on an A3-egfp fragment by using an Actin3-F/R primer, and carrying out double enzyme digestion through EcoR I/Sph I to connect the fragment to a pMD18-T plasmid to obtain T-A3-egfp; after Sna I/Sph I is used for double digestion of pFastBacDual-polyhedrin and T-A3-egfp, target fragments are recovered by glue and then connected to obtain recombinant plasmid pFastBacDual-polyhedrin-A3-egfp. After the T-A3-egfp is subjected to Nco I/Sph I double enzyme digestion, the T-A3-egfp is connected with MCS-F/MCS-R mixed pairing solution to obtain T-A3-MCS; T-A3-MCS and pFastBacDual-polyhedrin are subjected to Sna I/Sph I double enzyme digestion, target fragments are recovered and are then connected to obtain recombinant plasmid pFastBacDual-polyhedrin-A3-MCS; taking the extracted total RNA of the midgut tissue of the bombyx mori p50 as a template, carrying out reverse transcription to obtain a cDNA library, taking the cDNA library as the template, amplifying a Bmlispase-1 fragment by using a primer pair Bmlispase-F/R, carrying out double enzyme digestion by using Nco I/Sph I, and then connecting the amplified fragment to pFastBacDual-polyhidrin-A3-MCS to obtain pFastBacdual-polyhidrin-A3-Bmlispase-1. All clones were verified by sequencing by Biotechnology engineering (Shanghai) Inc.
The resulting pFastBacDual-polyhedrin-A3-MCS vector was prepared by the method described above.
TABLE 1 primers used for cloning
Preferably, the specific method for constructing the recombinant virus is as follows: the constructed recombinant plasmids pFastBacDual-polyhedrin-A3-egfp, pFastBacDual-polyhedrin-A3-Bmlispase-1 transformation of E.coli DH10Bac delta EGT cells to construct recombinant Bacmid, according toExpression System instructions for identification, purification and extraction of recombinant Bacmid. The BmN cells were cultured at 27 ℃ in an insect cell culture medium TC-100 containing 10% fetal bovine serum. mu.L of Cellffectin reagent (invitrogen USA) was mixed with 1. mu.g of recombinant Bacmid, BmN cells were transfected, and the condition of the cells was observed with a fluorescence microscope Olympus SZX 12. And collecting virus culture solution on the 4 th day after transfection, infecting the BmN cells again, and collecting the cells and the culture solution on the 4 th day after infection to obtain high-titer virus solution. Viral titers were determined by 50% endpoint dilution.
All the cloned genes were examined for expression: detecting the expression of Bmlispase-1 by using a Western blot method: after SDS-PAGE electrophoresis of cell lysate, transferring a protein band to a PVDF membrane by adopting a wet transfer membrane (100V, 60min), washing for 1 time by TTBS, then sealing for 3 hours at room temperature by using 5% defatted milk powder, washing for three times by TTBS, and adding a goat anti-mouse polyclonal antibody with a His label (1: 10000 (V/V)); GenScript, USA ], 4 ℃ overnight, TTBS 3 times. Then using a goat anti-mouse secondary antibody marked by HRP (horse radish peroxidase) (1: 20000 (v/v); GenScript, USA ] incubation for 1h at RT, three TTBS washes, one TBS wash and visualization with DBA visualization kit (Qiagen). The expression status of egfp and polyhedrin was observed by Olympus SZX12 fluorescence microscope.
Preferably, the genes involved in viral replication are selected in step (4): lef-3, helicase, lef-1, lef-2, dnapoly, dbp, lef-11, me53, lef-7 and ie-1 were investigated, and qRT-PCR was performed, respectively, using the primers shown in Table 2. The specific method comprises the following steps: equivalent amounts of recombinant viruses egfp, Bmlispase-1 [ MOI (multiplicity of infection) ═ 6]Separately infecting six-well BmN cells in logarithmic growth phase (about 10)6/ml), collecting the BmN cells 6h after infection; at the same time, the remaining cell culture solution was removed, the cells were washed with Phosphate Buffered Saline (PBS), and 2ml of TC-100 (containing 10% fetal calf serum) was added to continue the culture. Collecting cells and culture solution 12h, 24h, 36h, 48h, 60h and 72h after infection, respectively, and ultracentrifuging (25000 rpm/m)in, 1h 30min, 4 ℃), all collected samples were suspended in 1ml TRIzol (invitrogen, USA), and total RNA was extracted by one step. Then digested with DNase I (Takara, China). Total RNA quality was determined by 260/280 absorbance and electrophoresis. cDNA was synthesized using reverse transcriptase (Takara, China), and the concentration of cDNA was totally diluted to 100 ng/. mu.L usingThe PrimeScriptTM RT-PCR kit (Takara, China) was used for Real-Time PCR detection, and the experiment was performed on a Bio-Rad Chromo 4 instrument. The experimental procedure was performed as described in the specification, with 3 replicates per sample.
TABLE 2 primers for qRT-PCR of genes associated with viral replication
Northern Blot is adopted to verify the expression change of DBP, and the specific method is as follows: respectively electrophoresing 6 μ g of total RNA extracted from 1.4 in formaldehyde-denatured agarose, and transferring membrane by semidry method (3 mA/cm)235min), transferring the RNA band onto a nitrocellulose membrane, carrying out ultraviolet crosslinking for 3 min at the wavelength of 254nm, then hybridizing with a DBP probe labeled and combined with a DIG-High Prime (Roche, Switzerland), washing twice by using a washing buffer solution, incubating with an Anti-DIG-AP antibody for 30min, and finally developing by using a newly prepared substrate developing solution.
The specific method for verifying the interaction between the protein and the nucleic acid by the EMSA method is as follows:
(1) vector construction, prokaryotic protein expression and purification
Vector construction: and (3) taking the midgut cDNA of the fifth age of p50 as a template, amplifying the Bmlispase-1 by using a primer pair DBP-F1/R1, carrying out double enzyme digestion by using EcoR I/Not I, and connecting the product to pGEX-4T-1 to obtain the positive recombinant plasmid pGEX-4T-1-Bmlispase-1.
Prokaryotic protein expression: selecting monoclonal thallus, inoculating into a test tube containing 3ml LB culture solution with 50 mug/ml Amp, shaking overnight at 37 ℃; inoculating into 30ml LB culture solution of 50 μ g/ml Amp at a ratio of 1:100, and shaking at 37 deg.C until the thallus OD600 is 0.6-0.8; adding IPTG to the final concentration of 0.5mM, shaking overnight at 20 ℃, and inducing the expression of the fusion protein; centrifuging the bacterial liquid at 4000r/mim for 10min, discarding the supernatant, and resuspending the bacterial precipitate with PBS; after the resuspension was sonicated, 12% SDS-PAGE was carried out and the bands were visualized by Coomassie blue staining.
And (3) purifying an expression product: using a low-pressure chromatography system, loading the supernatant solution to a GST affinity chromatography column pre-balanced by GSTBinding-Buffer at the flow rate of 0.5 ml/min; flushing with GST Binding-Buffer at a flow rate of 0.5ml/min until the effluent OD280 value reaches the baseline; eluting the target protein with GST Elution-Buffer (20mM Tris-HCl, 50mM GSH, 0.15M NaCl, pH8.0) at a flow rate of 1ml/min, and collecting the effluent; adding the collected protein solution into a dialysis bag, and dialyzing overnight by using 20mM Tris-HCl, 0.15M NaCl, pH8.0; 12% SDS-PAGE and WesternBlot analysis were performed.
(2)EMSA
Preparing a probe: the biotin-labeled probe was synthesized according to the Lightshift Cheminimescent EMSA Kit (Thermo USA).
Electrophoresis: preparing 6% non-denatured polyacrylamide gel; pre-electrophoresis at 4 deg.c and 100V for 60 min; reacting the purified protein and the probe in a binding buffer solution, and standing at room temperature for 40 min; adding 5 mu L of Loading Buffer, mixing uniformly and Loading; electrophoresis was stopped at 4 ℃ and 100V until the length of the gel was 2/3.
Film transfer: soaking nylon membrane in 0.5 × TBE for 15min, sequentially placing sponge, filter paper, gel, nylon membrane, filter paper and sponge according to sandwich method, and fixing mesh plate; the gel faces the cathode and is inserted into an electrophoresis tank, and 0.5 xTBE and 300mA constant current are poured into the electrophoresis tank for 30 min; and (4) ultraviolet crosslinking.
Washing the membrane and detecting signals: method is provided withThe Chemilmescent EMSA Kit (Thermo USA) states the procedure. Nylon membrane is sealed by sealing buffer solution, combined by horse radish streptavidin peroxidase, rinsed and balancedAfter buffer equilibration, Substrate work Solution (Substrate work Solution) reaction, the machine was exposed and the results recorded.
Preferably, the specific method for analyzing the dbp promoter activity lacking the Bmlispase-1 binding site in the step (4) is as follows: directly synthesizing a dbp promoter dbp-65bp sequence without a binding site, adding enzyme cutting sites EcoR I and BamH I at two ends, cloning dbp-65bp into pFastBac1-MCS-egfp through double enzyme cutting, constructing a recombinant virus, infecting BmN cells with the same amount of the recombinant virus, observing the cell state 48h after infection, and verifying the expression amount of the egfp by using a Western Blot method.
The materials and sources used in this application are as follows: the tested silkworm varieties are p50 and 54A, and the bombyx mori BmN cells, the vectors pFastBac1 and the pGEX-4T-1 are all stored in a silkworm genetic improvement key laboratory of the department of agriculture. The pPIGA3GFP plasmid was gifted by doctor Tamura and doctor Chavancy.
Silkworm midgut tissue (third day of p50 fifth age), pFastBacDual insect cell expression vector, BmNPV genome, BmNPV cell, pcDNA3.0 (engineered with an Actin3(A3) initiated egfp).
Plasmid vector pMD18-T,Premix Ex TaqTMII, Oligo dT, dNTP, LA Taq enzyme, T4DNA ligase, M-MLV reverse transcriptase, Proteinase K, restriction enzyme were purchased from TaKaRa engineering Co., Ltd. Fetal bovine serum, Cellffectin transfection reagent, TRIzol, RNase Inhibitor were purchased from Invitrogen corporation. Insect cell culture medium TC-100 was purchased from PAA, Germany. His Tag goat anti-mouse polyclonal antibody, horseradish peroxidase labeled secondary IgG (H + L).
Has the advantages that: (1) on the basis of constructing recombinant viruses capable of expressing Bmlispase-1, the invention analyzes the influence of Bmlispase-1 on virus replication related genes in cells, and researches the action site of Bmlispase-1 by using EMSA, thereby clarifying the mechanism of inhibiting the replication and proliferation of BmNPV by Bmlispase-1; (2) the method skillfully avoids the defects that the establishment of a transgenic cell line needs a long time, and the culture of insect cells is easily polluted, long in culture time and easy to degenerate; (3) the method of the invention can increase the expression level of the candidate gene along with the proliferation of the virus, and the inhibition effect on the BmNPV is continuously enhanced, so that the target gene information can be rapidly obtained.
Drawings
FIG. 1 is a recombinant plasmid construction diagram, wherein A is a pFastBacDual-polyhedrin-A3-egfp construction diagram, and B is a pFastBacdual-polyhedrin-A3-Bmlispase-1 construction diagram.
FIG. 2 is a PCR identification diagram of recombinant Bacmid capable of expressing Bmlispase-1, egfp, wherein M-1: DL2000 Marker; m-2: lambda-EcoT 14I digest; lane 1-2, recombinant virus egfp; lane 3-4 recombinant virus Bmlispase-1.
FIG. 3 is a gene expression verification diagram in which A: the control group expressed egfp (160 ×); b: recombinant virus formed viral polyhedra (640 ×); c: western blot to detect the expression of Bmlispase-1, lane 1: infection with recombinant virus Bmlispase-1, lane 2: and (4) a control group.
FIG. 4 is a graph showing the change in the expression level of genes involved in viral replication, in which A is a standard curve, B is dbp gene, C is ie-1 gene, D is helicase gene, E is dnapoly gene, F is me53 gene, G is lef-1 gene, H is lef-2 gene, I is lef-3 gene, J is lef-7 gene, and K is lef-11 gene; the differences were very significant.
FIG. 5 is a graph of Northern Blot method for verifying the expression change of DBP at different time points, wherein Lip is Bmlispase-1 recombinant Bacmid, and Control is egfp recombinant Bacmid.
FIG. 6 is a graph showing the variation of copy numbers of genes involved in viral replication, wherein A is ie-1 gene and B is a standard curve; the differences were very significant.
FIG. 7 is a SDS-PAGE photograph showing the expression of Bmlispase-1 gene; wherein M is the protein molecular mass standard; 1, no induction; 2, after induction at 20 ℃; 3, inducing crushing at 20 ℃ and then clearing the supernatant; precipitating after induced crushing at the temperature of 4:20 ℃.
FIG. 8 is an analysis of Bmlispase-1 fusion protein; wherein A is SDS-PAGE analysis and B is Western Blot analysis.
FIG. 9 is a graph showing the results of EMSA analysis; wherein, A is the length of dbp promoter and the design site of probe, B is exposure for 1 minute, and C is exposure for 3 minutes.
FIG. 10 is a graph of the activity analysis of the dbp promoter lacking the binding site; wherein A is a cell fluorescence image, B is a Western Blot analysis, 1 is dbp-75bp, and 2 is dbp-65 bp.
Detailed Description
The following examples further illustrate the present invention but are not to be construed as limiting the invention. Modifications and substitutions to methods, procedures, or conditions of the invention may be made without departing from the spirit and substance of the invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art.
Example 1 construction and verification of recombinant plasmid and recombinant virus capable of expressing Bmlispase-1 and egfp
Respectively transforming the recombinant plasmids into DH10Bac cells to obtain recombinant Bacmid according toExpression System instructions for identification, purification and extraction of recombinant Bacmid. Recombinant Bacmid identification was performed with M13-F/R. The results show (fig. 2): positive recombinant Bacmid was obtained, lane 1 is recombinant Bacmid-egfp (control group), and lane 3 is recombinant Bacmid-Bmlispase-1 (test group). And (3) transfecting the recombinant Bacmid into the BmN cell to obtain a recombinant virus, and determining the virus titer.
BmN cells are infected by the recombinant viruses Bmlispase-1 and egfp respectively, and the expression conditions of the egfp and polyhedrin are observed by an Olympus SZX12 fluorescence microscope. At 72h, a lot of green fluorescence appeared in Bacmid-egfp infected BmN cells, indicating that egfp could be expressed (FIG. 3. A); a large number of viral polyhedra appeared in and outside BmN cells infected with Bacmid-Bmlispase-1 (FIG. 3. B); cells were harvested 96h after infection, proteins were extracted, and expression of Bmlispase-1 was confirmed by Western Blot (FIG. 3. C). The above results indicate that all gene clones were successful and that further experiments can be carried out.
Example 2 qRT-PCR detection of the Effect of Bmlispase-1 on Virus replication-related genes and changes in the viral genome
The BmNPV needs the participation of the following enzymes in the processes of replication and proliferation: DNA polymerase (dnapoly) which extends DNA from the 3' -OH of the RNA primer in the 5' to 3' direction; helicase having the biochemical properties of ATPase and Helicase and the ability to bind to ssDNA and dsDNA; DNA primer enzyme, LEF-1 and primer enzyme related factor, LEF-2; a single-stranded DNA binding protein (SSB) LEF-3 having an interaction with an alkaline nuclease and capable of regulating the function of the enzyme and also capable of unwinding and annealing DNA according to its concentration or redox state; the second SSB is the DNA Binding Protein (DBP) necessary for the production of the nucleocapsid and pathogenic matrix; IE-1 is transcribed early in infection and continues to be transcribed at a later stage, IE1 is essential for transient DNA replication and is an essential gene, since baculovirus with this gene deletion cannot survive; LEF-11 stimulates late gene transcription, but is not required for transient DNA replication. However, the lef-11 knockout AcMNPV baculovirus, when transfected into Sf-9 cells, is unable to synthesize DNA or undergo late gene transcription; the deletion me53 prevents the virus from forming mature virus particles, thereby influencing the replication effect of the virus; lef-7 stimulated transient DNA replication, and when deleted, infection in Tn368 cells was unaffected, but in Sf21 and s.exigua cells, DNA replication was 10% of controls. A reduction in DNA synthesis was also observed in the absence of lef-7 in BmNPV.
Ie-1 was ligated into the vector pMD18-T, plasmid concentration was determined to be 247.3 ng/. mu.L, and plasmid copy number was determined to be 5.08X 1010copies/mL, the plasmid was diluted 10-fold and q-PCR was performed. The results are shown in FIG. 4. A: the standard curve equation is that y is-3.6857 x +43.827, R2=0.9997。
Equivalent recombinant viruses egfp and Bmlispase-1 respectively infect the BmN cells. Collecting cells and culture solution 6, 12, 24, 36, 48, 60 and 72 hours after infection, extracting total RNA after ultracentrifugation, carrying out reverse transcription to synthesize cDNA, detecting the expression levels of lef-3, helicase, lef-1, lef-2, dnapoly, dbp, lef-11, me53, lef-7 and ie-1 according to the same method, and calculating the copy number of the expression level of the gene to be detected according to a formula. The results show that: at all sampling time points, the expression level of dbp in the cells of the recombinant virus expressing Bmlispase-1 was lower than that of the control (egfp), wherein Bmlip of 24, 36, 48 and 60 hoursThe expression level of dbp in BmN cells infected with ase-1 was 1.70X 107、6.45×106、2.52×105、2.45×107(copy number), 33.93%, 59.16%, 12.41%, 50.43% of the controls, respectively, all achieved very significant differences (fig. 4. B). The expression level measurements of the remaining 9 genes revealed (FIG. 4.A, C-K) that the gene expression levels in the test group were slightly lower than those in the control group, and that the trend of the curve was consistent with dbp.
We verified the change in expression of dbp at different time points using the Northern Blot method. Total RNA from BmN cells at various time points after infection with the recombinant virus was bound to dbp-DNA digoxigenin-labeled probes by northern Blot and visualized with NBT/BCIP (FIG. 5): the expression level of all dbps in the test group is obviously lower than that of the Control group, and the change trend is basically consistent with the qRT-PCR result.
On the other hand, cells were infected and collected using the above method, and genomic DNA was extracted, and the copy value of ie-1 was detected using a standard curve method (FIG. 6. B). The copy number of ie-1 was lower in the cells of the test group at all time points than in the control (FIG. 6.A), wherein the copy numbers of ie-1 were 7.09X 10 for 12, 24, 36, 48, 60h, respectively6、3.63×108、3.59×109、5.56×109、4.70×109Significant differences were achieved at 38.58%, 20.04%, 42.81%, 53.74%, 65.13% of the controls, respectively. ie-1 exists in a single copy in the BmNPV genome, and changes in copy value represent changes in the BmNPV genome. DBP (Bm16), known as DNA Binding Protein (DBP). It has properties similar to LEF-3, and is capable of melting and annealing DNA. DBP also competes with LEF-3 for binding sites on ssDNA templates and protects ssDNA from hydrolysis by the baculovirus Alkaline Nuclease (AN)/LEF-3 complex. DBP is not a virion structural protein, but it is an integral part of the pathogenic matrix and is also necessary for the production of nucleocapsids. Furthermore, although viral DNA synthesis occurs in cells transfected with the virus constructed with the knock-out DBP, the levels are lower than those of the control virus, indicating that DBP may be necessary for normal DNA synthesis levels or nascent viral DNA stability. DBP can protect the mature viral genome from nuclease attack and prior to packaging into virionsIt is stabilized. On the other hand, the processing of replicative intermediates requires the unwinding and renaturation activities of DBP, which may involve annealing and strand invasion reactions of DNA recombination, which is critical for the complete replication and processing of the baculovirus genome. In conclusion, the inhibition of the expression of the virus dbp is probably the key of the Bmlispase-1 in inhibiting the replication and proliferation of the virus.
Example 3 Bmlispase-1 analysis of the site of action of dbp upstream promoter
(1) Bmlispase-1 prokaryotic expression and purification
The middle intestine cDNA of bombyx mori p50 fifth-instar day 3 is used as a template, Bmlispase-1 is amplified by PCR, and is connected to pGEX-4T-1 after double enzyme digestion to obtain a positive recombinant plasmid pGEX-4T-1-Bmlispase-1. The recombinant plasmid was transformed into BL21 cells, monoclonal cells were selected and inoculated into LB medium, expression of the fusion protein was induced with IPTG at 20 ℃ and the bacterial solution was disrupted by ultrasonication and then subjected to 12% SDS-PAGE, and bands were visualized by Coomassie blue staining (FIG. 7). The results show that: in the thalli which are not induced by IPTG, the expression quantity of Bmlispase-1 is very little; the Bmlispase-1 content in the supernatant and the sediment of the induced cells is increased, and the molecular weight of the fusion protein is about 59.63KD (the molecular weight of the Bmlispase-1 is 31.73KD, and the molecular weight of GST-tag is about 27.90 KD).
The fusion protein constructed on the pGEX-4T-1 vector and induced by low temperature is expressed in the form of supernatant, and the GST affinity purification of the supernatant of the fusion protein is carried out in the next step.
Using a low-pressure chromatography system to sample the supernatant solution to a GST Binding-Buffer pre-balanced GST affinity chromatography column; eluting the target protein by GST Elution-Buffer when the effluent OD280 value reaches a baseline, and collecting the effluent; adding the collected protein solution into a dialysis bag for dialysis overnight; 12% SDS-PAGE and Western Blot analysis were performed. The results are shown in FIG. 8: in the sample after the cell is ultrasonically crushed and the effluent after chromatography, besides Bmlispase-1 fusion protein, a large amount of other proteins exist; in contrast, only the Bmlispase-1 fusion protein was present in the dialysis eluate (FIG. 8. A). Western Blot analysis shows that the Bmlispase-1 fusion protein is a monomeric protein. The above results illustrate that: the purified protein after the Bmlispase-1 prokaryotic expression has high purity and can be used for EMSA experiments.
(2) EMSA analysis
In the BmNPV genome, the sequence size between an open reading frame of a dbp gene and an adjacent orf _17 gene is 75bp, promoter activity analysis is carried out on a promoter region (dbp-75bp) of the dbp gene and an upward extension promoter region (dbp-126bp) (figure 9.A), the two sequences are cloned into pFastBac1-MCS-EGFP, and after Bacmid is constructed by a Bac-to-Bac system, silkworm BmN cells are transfected, green fluorescence is observed, but the fluorescence difference is not obvious.
3 biotin-labeled probes were designed and synthesized from the sequence (dbp-126bp) with 10bp repeats between adjacent probes (FIG. 9. A). The 3 probes are respectively mixed with Bmlispase-1 protein, and the combination of the probes and the protein is detected by non-denaturing polyacrylamide gel electrophoresis, membrane transfer, ultraviolet crosslinking, membrane washing and signal detection. The results are shown in FIG. 9. B: binding bands exist between the probes 2 and 3 and the Bmlispase-1 protein, and the probes 2 and 3 are supposed to be mutually bound with the Bmlispase-1.
Since a repeated sequence exists between the probes 2 and 3, the sequence is analyzed by a promoter binding element by using GeneQuest software, and a binding site of the c-Myb transcription factor (TTCAAT) exists in the repeated sequence region. To determine whether this binding site is a binding region of the Bmlispase-1 protein. We performed a second EMSA experiment.
Biotin-labeled probe 4 was synthesized (FIG. 9.A) and mixed with Bmlispase-1 for EMSA analysis (FIG. 9. C). The results show that: probe 4, which lacks the c-Myb transcription factor binding site, has no binding band and can be determined to be the binding region of Bmlispase-1.
Example 4 Activity analysis of dbp promoter lacking binding site
Synthesizing a dbp promoter (dbp-65bp) sequence lacking a binding site, adding restriction enzyme sites (EcoRI and BamH I) at two ends, cloning dbp-65bp into pFastBac1-MCS-EGFP by double restriction enzyme, constructing a recombinant virus, infecting cells after transfection, observing weak fluorescence 48h after infecting the cells, and having obvious difference compared with the activity of the promoter (dbp-75bp) (figure 10. A).
And (3) infecting BmN cells with recombinant viruses carrying promoters of dbp-75bp and dbp-65bp, collecting the cells on the 5 th day, extracting total protein, and performing Western Blot experiment verification by using equivalent protein. The experimental results show that: the expression level of green fluorescent protein in dbp-65bp was significantly lower than that in dbp-75bp (FIG. 10. B). The above results illustrate that: the Bmlispase-1 competitively binds with the dbp upstream promoter binding element, so that the expression quantity of dbp is reduced, the virus titer is reduced, and the effect of inhibiting virus replication and proliferation is achieved.
And (4) conclusion:
silkworm hemopus diseases are extremely harmful to the silkworm industry in China. The breeding of antiviral silkworm varieties and the research of silkworm genes for resisting BmNPV have been always concerned by the industry. By using the technologies of transgenosis, overexpression and the like, a plurality of genes are determined to have the BmNPV resistance activity. The invention reports a method for constructing a recombinant virus capable of expressing Bmlispase-1, researches the interaction of the Bmlispase-1 and the virus, and reduces the expression quantity of dbp due to the combination of the Bmlispase-1 and a dbp upstream promoter binding element, thereby achieving the research result of inhibiting the replication and proliferation of the virus. Provides a new method for researching the mechanism of inhibiting virus replication and proliferation by silkworm gene.
The research finds that: bmlispase-1 can inhibit the expression of dbp of BmNPV. The expression level of dbp 48h after infection of BmN cells with the recombinant virus was 12.41% of that of the control, and reached the lowest expression level, which was also the lowest difference (FIG. 4. B). While the expression levels of the other 9 genes were slightly lower than the control and the trend of the curve was consistent with dbp (FIG. 4.A, C-K). In the test group, the copy number of the viral genome (24h) was 20.04% of the control, reaching the difference minimum, but the viral genome increased continuously throughout the infection and reached equilibrium at 48h (fig. 6). The difference between these 2 curves may be related to the dbp function. The viral DNA synthesis in cells transfected with DBP-deficient viruses is lower than that of normal viruses, and DBP is required for normal DNA synthesis levels or for nascent viral DNA stability. Additionally, DBP can protect the mature viral genome from nuclease attack. The processing of DNA replication intermediates requires unwinding and renaturation activities of DBP, which is critical for the complete replication and processing of the baculovirus genome. The replication, assembly and Bmlispase-1 expression of the recombinant virus exist in the sameIn the environment, the expression level of Bmlispase-1 is increased along with the replication and proliferation of the virus, and the inhibition effect on BmNPV is also enhanced. However, the expression profiles of all the genes involved in viral replication were identical, with 0-48 h being high first and low later, which is likely to be the same as under the present experimental conditions (about 10 infection with MOI 6 virus)6BmN cells/ml, medium renewal after 6 h) release of virions, lysis of cells.
The binding site of Bmlispase-1 contains a 6 base (TTCAAT) motif, which is the site of action of the c-Myb transcription factor. MyB transcription factor is widely distributed in plants, animals and fungi, c-Myb is necessary for normal hematopoiesis, and mice with knockout of c-Myb cause embryonic death due to hematopoietic failure; c-Myb plays a crucial role in the activation process of human NK cells (natural killercells); in addition, the OsMYB2 can obviously enhance the cold resistance, salt resistance and drought resistance of rice. Whether the Bmlispase-1 has the related function of the MyB family or not is further researched.
The binding of Bmlipitase-1 to the binding site is weak, which is probably related to the fact that Bmlipitase-1 is obtained through prokaryotic expression. Although the protein expressed by the pronucleus has high efficiency and high synthesis speed, the protein expressed by the pronucleus cannot generate glycosylation, phosphorylation and other post-translational modifications, and the biological activity and the function of the synthetic protein are influenced.
At present, the research on the inhibition mechanism of silkworm virus-resistant related genes on BmNPV amplification is not reported yet. However, the establishment of the transgenic cell line requires a long time, and the insect cell culture has the characteristics of easy pollution, long culture time and easy degeneration, so the establishment of the transgenic cell line is difficult. The method for constructing the recombinant virus capable of expressing the Bmlipiase-1 is innovatively adopted, so that the problems are ingeniously avoided; furthermore, this research approach enables the expression level of the candidate gene to increase with the proliferation of the virus, and the effect of inhibiting BmNPV to be enhanced, thereby enabling the target gene information to be obtained quickly. The research provides a new theoretical basis for preventing and treating lepidoptera insect viruses and provides a new research idea for further discussing the inhibition mechanism of silkworm genes on the viruses.
Sequence listing
<110> university of Jiangsu science and technology
<120> method for studying expression of gene related to inhibition of BmNPV DNA replication by silkworm gene
<160>32
<170>SIPOSequenceListing 1.0
<210>1
<211>31
<212>DNA
<213> silkworm (Bombyx mori)
<400>1
atcggatcca tgccgaatta ttcatacacc c 31
<210>2
<211>30
<212>DNA
<213> silkworm (Bombyx mori)
<400>2
atcaagcttt taatacgccg gaccagtgaa 30
<210>3
<211>35
<212>DNA
<213> silkworm (Bombyx mori)
<400>3
aacgaattcg tatacgagct caagcttgat cgcgt 35
<210>4
<211>31
<212>DNA
<213> silkworm (Bombyx mori)
<400>4
aacgcatgct tacttgtaca gctcgtccat g 31
<210>5
<211>74
<212>DNA
<213> silkworm (Bombyx mori)
<400>5
catgggaatt cgcgcggccg cggtcgacgt aggcctcacc cgggatctcg agtttgctag 60
caacagctgg catg 74
<210>6
<211>66
<212>DNA
<213> silkworm (Bombyx mori)
<400>6
ccagctgttg ctagcaaact cgagatcccg ggtgaggcct acgtcgaccg cggccgcgcg 60
aattcc 66
<210>7
<211>29
<212>DNA
<213> silkworm (Bombyx mori)
<400>7
aacccatgga tgcctgatgg cgagggtgt 29
<210>8
<211>48
<212>DNA
<213> silkworm (Bombyx mori)
<400>8
aacgcatgct tagtgatggt gatggtgatg gaaaggccaa ctgctgcc 48
<210>9
<211>17
<212>DNA
<213> silkworm (Bombyx mori)
<400>9
gttttcccag tcacgac 17
<210>10
<211>17
<212>DNA
<213> silkworm (Bombyx mori)
<400>10
caggaaacag ctatgac 17
<210>11
<211>27
<212>DNA
<213> silkworm (Bombyx mori)
<400>11
ccggaattca tgccggatgg cgaaggc 27
<210>12
<211>30
<212>DNA
<213> silkworm (Bombyx mori)
<400>12
aatgcggccg cttaaaacgg ccaactactg 30
<210>13
<211>20
<212>DNA
<213> silkworm (Bombyx mori)
<400>13
<210>14
<211>19
<212>DNA
<213> silkworm (Bombyx mori)
<400>14
<210>15
<211>20
<212>DNA
<213> silkworm (Bombyx mori)
<400>15
<210>16
<211>21
<212>DNA
<213> silkworm (Bombyx mori)
<400>16
aaagtacaaa tagccttcga c 21
<210>17
<211>21
<212>DNA
<213> silkworm (Bombyx mori)
<400>17
aagagtcatg tataccggca a 21
<210>18
<211>22
<212>DNA
<213> silkworm (Bombyx mori)
<400>18
atatgcggaa tgtacaaacg ta 22
<210>19
<211>23
<212>DNA
<213> silkworm (Bombyx mori)
<400>19
acatttgtat gaaagaatgc gta 23
<210>20
<211>22
<212>DNA
<213> silkworm (Bombyx mori)
<400>20
gttttcacat ttggtacacg aa 22
<210>21
<211>21
<212>DNA
<213> silkworm (Bombyx mori)
<400>21
gcccacattt aactataacg a 21
<210>22
<211>20
<212>DNA
<213> silkworm (Bombyx mori)
<400>22
<210>23
<211>23
<212>DNA
<213> silkworm (Bombyx mori)
<400>23
ggataagaac aaaactagcg aac 23
<210>24
<211>21
<212>DNA
<213> silkworm (Bombyx mori)
<400>24
ttattcatgt ccgtcatctg c 21
<210>25
<211>19
<212>DNA
<213> silkworm (Bombyx mori)
<400>25
<210>26
<211>20
<212>DNA
<213> silkworm (Bombyx mori)
<400>26
<210>27
<211>20
<212>DNA
<213> silkworm (Bombyx mori)
<400>27
<210>28
<211>22
<212>DNA
<213> silkworm (Bombyx mori)
<400>28
atataatcat ttcgttgtgc at 22
<210>29
<211>21
<212>DNA
<213> silkworm (Bombyx mori)
<400>29
ctgccaatta tcacttcacg a 21
<210>30
<211>21
<212>DNA
<213> silkworm (Bombyx mori)
<400>30
ttcaatcaac tttctcgcca a 21
<210>31
<211>21
<212>DNA
<213> silkworm (Bombyx mori)
<400>31
ttctcaagat gtgtgcaacg a 21
<210>32
<211>21
<212>DNA
<213> silkworm (Bombyx mori)
<400>32
acgactaagc ataataggca a 21
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911086586.7A CN110940807A (en) | 2019-11-08 | 2019-11-08 | Method for researching expression of bombyx mori gene for inhibiting BmNPV DNA replication related gene |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911086586.7A CN110940807A (en) | 2019-11-08 | 2019-11-08 | Method for researching expression of bombyx mori gene for inhibiting BmNPV DNA replication related gene |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110940807A true CN110940807A (en) | 2020-03-31 |
Family
ID=69907281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911086586.7A Pending CN110940807A (en) | 2019-11-08 | 2019-11-08 | Method for researching expression of bombyx mori gene for inhibiting BmNPV DNA replication related gene |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110940807A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6485937B1 (en) * | 1999-10-15 | 2002-11-26 | The Rockefeller University | System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae |
CN101372684A (en) * | 2008-07-16 | 2009-02-25 | 南阳师范学院 | A simple and efficient method for constructing recombinant baculovirus |
US20120149010A1 (en) * | 2009-08-17 | 2012-06-14 | Genethon | Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
CN102925484A (en) * | 2012-11-21 | 2013-02-13 | 西南大学 | Application and recombinant vector of bombyx mori nuclear polyhedrosis virus polygene inverted repeat sequence and bombyx mori lipase-1 gene |
CN104017826A (en) * | 2014-05-30 | 2014-09-03 | 江苏大学 | Engineered bombyx mori baculovirus vector and method of increasing the NS1 expression amount by utilization of the vector |
-
2019
- 2019-11-08 CN CN201911086586.7A patent/CN110940807A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6485937B1 (en) * | 1999-10-15 | 2002-11-26 | The Rockefeller University | System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae |
CN101372684A (en) * | 2008-07-16 | 2009-02-25 | 南阳师范学院 | A simple and efficient method for constructing recombinant baculovirus |
US20120149010A1 (en) * | 2009-08-17 | 2012-06-14 | Genethon | Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
CN102925484A (en) * | 2012-11-21 | 2013-02-13 | 西南大学 | Application and recombinant vector of bombyx mori nuclear polyhedrosis virus polygene inverted repeat sequence and bombyx mori lipase-1 gene |
CN104017826A (en) * | 2014-05-30 | 2014-09-03 | 江苏大学 | Engineered bombyx mori baculovirus vector and method of increasing the NS1 expression amount by utilization of the vector |
Non-Patent Citations (1)
Title |
---|
张园: "家蚕脂肪酶Ⅰ对BmNPV复制相关基因dbp的作用研究", 《中国优秀硕士学位论文全文数据库 农业科技辑》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2022527017A (en) | Integration of nucleic acid constructs into eukaryotic cells using oryzias-derived transposases | |
CN102433340B (en) | Resistance key gene BmPGRP2 of silkworm to nuclear polyhedrosis virus and application thereof | |
JP2022527016A (en) | Transfer of nucleic acid constructs to the eukaryotic genome using transposases derived from Amielois | |
CN104946649B (en) | A kind of Rice Anther specific expression promoter OsAnth1 | |
CN113490683A (en) | Gray spot resistance-related protein ZmWAK-RLK and coding gene and application thereof | |
CN106755089B (en) | Cell line for expressing goat lymphocyte activating molecules and construction method and application thereof | |
CN109053904B (en) | APPV-E2 fusion protein, preparation method, application and vaccine thereof | |
Dickison et al. | Deletion of AcMNPV ac146 eliminates the production of budded virus | |
Reed et al. | Shotgun sequencing of the negative-sense RNA genome of the rhabdovirus Maize mosaic virus | |
KR20120092647A (en) | Enchanced gene expression in algae | |
AU678982B2 (en) | Insect viruses and their uses in protecting plants | |
CN111100868B (en) | Female promotion gene FERR and female inhibition gene FERR-R of populus deltoides and application thereof | |
US9587248B2 (en) | Mayetiola destructor susceptibility gene one (Mds-1) and its application in pest management | |
CN110940807A (en) | Method for researching expression of bombyx mori gene for inhibiting BmNPV DNA replication related gene | |
CN108998455B (en) | Bombyx mori nuclear polyhedrosis virus inducible 39K promoter and its recombinant vector and application | |
CN112961865A (en) | Recombinant trastuzumab expressed by using gene editing chicken bioreactor and application | |
Cai et al. | Characterization of Wuhan Nodavirus subgenomic RNA3 and the RNAi inhibition property of its encoded protein B2 | |
CN103642807B (en) | Enhanced bombyx mori nuclear polyhedrosis virus inducible promoter En39k and application thereof | |
JP2007228814A (en) | Gene cassette for expressing foreign protein and method for producing foreign protein | |
Zhang et al. | Cloning and rescue of the genome of Bombyx mori bidensovirus, and characterization of a recombinant virus | |
CN101974528A (en) | Pathogen-inducible promoter PXa13 and its application in regulating target gene expression under pathogen induction | |
CN114516903A (en) | Plant immune activation protein PlAvh23 secreted by phytophthora litchi and application thereof | |
Emery | Baculovirus expression vectors: choice of expression vector | |
CN112210556A (en) | A group of shRNA and recombinant adenovirus vectors targeting to interfere with IL-33 expression and their construction methods and applications | |
CN108727480B (en) | Transcription inhibition structure domain, coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200331 |